CSR Program: Strengthening Inclusive Mobile Health Services | Takeda Pharmaceuticals

Somalia has one of the world’s highest rates of under-five mortality and lifetime risk of maternal death, and over 90% of women and girls have been subjected to female genital mutilation (FGM). FGM can result in serious health consequences, including significant morbidity and health burden. Many health workers lack training on the prevention and management of FGM complications. This program aims to strengthen health systems by operating mobile, essential inclusive age-gender-responsive health care services, as well as developing mobile/outreach clinic standards and clinical guidelines for FGM management. This ensures even the most marginalized have access to affordable quality care.

Contact us if you'd like more information about our Global CSR Program.